首页|基于"网络药理学-分子对接-实验验证"探索珍珠通络丸治疗周围神经病变的作用机制研究

基于"网络药理学-分子对接-实验验证"探索珍珠通络丸治疗周围神经病变的作用机制研究

扫码查看
目的 系统研究珍珠通络丸治疗周围神经病变的药效物质和潜在作用机制。方法 基于TCMSP数据库并结合相关文献确定珍珠通络丸的活性成分;采用TCMSP、SwissTarget Prediction、GeneCard、OMIM和DisGeNET数据库预测珍珠通络丸活性成分靶点和周围神经病变相关靶点,取两者交集作为珍珠通络丸治疗周围神经病变的关键靶点,通过String数据库获得交集靶点之间的相互作用关系,并运用Cytoscape 3。9。1软件进行可视化分析;借助DAVID数据库对得到的关键靶点进行GO富集分析和通路注释分析;采用超高效液相色谱-四极杆/静电场轨道肼高分辨质谱联用仪(UHPLC-Q-Orbitrap HRMS)技术表征珍珠通络丸的主要化学成分,并进一步采用分子对接和动物、细胞实验探究珍珠通络丸治疗周围神经病变的作用机制。结果 本研究共筛选出珍珠通络丸147个潜在活性成分和333个交集靶点;GO功能和KEGG通络分析发现这些靶点主要涉及 MAPK signaling pathway、NF-κB signaling pathway、PI3K-Akt signaling pathway、MAPK级联、炎症反应等。经高分辨质谱进一步确认,并以Dgree值>中位数的活性成分为鉴定目标,从珍珠通络丸中共鉴定出33个主要活性成分。分子对接结果进一步显示珍珠通络丸中木犀草素、槲皮素、色氨酸、精氨酸和山柰酚与关键靶点之间具有良好的结合作用。Western blot实验结果显示木犀草素、槲皮素、色氨酸能显著抑制炎症细胞中MAPK8、P65和TNF蛋白的表达。动物实验表明,珍珠通络丸能够显著改善糖尿病周围神经病变大鼠的痛觉敏化,这可能与调节背根神经节中MAPK8、P65和TNF蛋白的表达有关。结论 珍珠通络丸中可能通过作用于MAPK8、P65和TNF靶点发挥治疗周围神经病变的作用,本研究为珍珠通络丸治疗周围神经病变作用机制和药效物质的深入研究奠定基础。
Discovery of Potential Mechanism of Zhenzhu Tongluo Wan for the Treatment of Peripheral Neuropathy Based on the Strategy of"Network Pharmacology,Mass Spectrometry Component Identification and Molecular Docking"
Objective This study aimed to systematically investigate the pharmacological substances and potential mechanisms of Zhenzhu Tongluo Wan in the treatment of peripheral nerve disorders.Methods Based on the TCMSP database and related literature,the active ingredients of Zhenzhu Tongluo Wan were determined.Target proteins for these active ingredients and those associated with peripheral neuropathy were predicted using the TCMSP,SwissTarget Prediction,GeneCard,OMIM,and DisGeNET databases.The intersection of these two sets of proteins was once considered a key target for the treatment of peripheral neuropathy.A protein-protein interaction(PPI)network of the intersection targets was constructed using the STRING database and analyzed using Cytoscape 3.9.1 software.Key targets obtained from the network were subjected to GO enrichment analysis and pathway annotation analysis using the DAVID database.The UHPLC-Q-Orbitrap HRMS technique was used to characterize the major chemical components of Zhenzhu Tongluo Wan.In addition,molecular docking,animal and cell experiments were performed to explore the mechanisms underlying the treatment of peripheral neuropathy with Zhenzhu Tongluo Wan.Results A total of 147 potential active ingredients and 333 intersection targets of Zhenzhu Tongluo Wan were screened.GO function and KEGG pathway analysis revealed that the major pathways involved include MAPK signaling pathway,NF-κB signaling pathway,PI3K-Akt signaling pathway,MAPK cascade and inflammatory response,among others.Based on high-resolution mass spectrometry analysis,33 major active ingredients were identified from Zhenzhu Tongluo Wan,focusing on those compounds with a Dgree value greater than the median.Molecular docking results further demonstrate good binding interactions between compounds such as luteolin,quercetin,tryptophan,arginine and kaempferol found inZhenzhu Tongluo Wan and key targets.Western blotting experiments showed that luteolin,quercetin and tryptophan could significantly inhibit the expression of MAPK8,P65 and TNF proteins in inflammatory cells.Animal experiments showed that Zhenzhu Tongluo Wan significantly improved hyperalgesia in rats with diabetic peripheral neuropathy,which may be related to the modulation of the expression of MAPK8,P65 and TNF proteins in the dorsal root ganglion.Conclusion Zhenzhu tongluo pills may play a role in the treatment of peripheral neuropathy by acting on the targets of MAPK8,P65 and TNF.This study lays a foundation for further research on the mechanism and pharmacodynamic substances of Zhenzhu Tongluo Wan in the treatment of peripheral neuropathy.

Zhenzhu Tongluo WanPeripheral neuropathyUHPLC-Q-Orbitrap HRMSChemical compositionNetwork pharmacologyMolecular docking

董鹏飞、周霖、王肖辉、薛连平、杜洋

展开 >

郑州大学第二附属医院,中医科 郑州 450000

郑州大学第一附属医院 郑州 450052

中南大学资源加工与生物工程学院 长沙 410012

郑州卷烟厂康复医院 郑州 450000

展开 >

珍珠通络丸 周围神经病变 UHPLC-Q-Orbitrap HRMS 化学成分 网络药理学 分子对接

2024

世界科学技术-中医药现代化
中科院科技政策与管理科学研究所,中国高技术产业发展促进会

世界科学技术-中医药现代化

CSTPCD北大核心
影响因子:1.175
ISSN:1674-3849
年,卷(期):2024.26(9)